References
- Hasen J., Boyar R. M., Shapiro L. R. Gonadal function in trisomy 21. Horm. Res. 1980; 12: 345–50
- Højager B., Peters H., Byskov A. G., Faber M. Follicular development in ovaries of children with Down's syndrome. Acta Paediatr. Scand. 1978; 67: 637–43
- Hsiang Y. H., Berkovitz G. D., Bland G. L., Migeon C. J., Warren A. C. Gonadal function in patients with Down syndrome. Am. J. Med. Genet. 1987; 27: 449–58
- Benda C. E. Down's syndrome. Grune and Stratton, New York 1969
- Bellone E., Tanganelli E., LaPlaca A., Daneri C. Menarca e fisiopatologia mestruale nella sindrome di Down. Minerva Ginecol. 1980; 32: 579–88
- Goldstein H. Menarche, menstruation, sexual relations and contraception of adolescent females with Down syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 1988; 27: 343–9
- Scola P. S., Pueschel S. M. Menstrual cycles and basal body temperature curves in women with Down syndrome. Obstet. Gynecol. 1992; 79: 91–4
- Tricomi V., Valenti C., Hall J. E. Ovulatory patterns in Down's syndrome. Am. J. Obstet. Gynecol. 1964; 89: 651–6
- Rani A. S., Jyothi A., Reddy P. P., Reddy O. S. Reproduction in Down's syndrome. Int. J. Gynaecol. Obstet. 1990; 31: 81–6
- Ragusa L., Alberti A., Proto C., Romano C., Colabucci F. Preliminary results after one year of recombinant human growth hormone treatment in four subjects with Down's syndrome. Growth Hormone Treatment In Down's Syndrome, S. Castells, K. E. Wisniewski. John Wiley & Sons, New York 1993; 199–202
- McCarthy J. J., Rockette H. E. Prediction of ovulation with basal body temperature. J. Reprod. Med. 1986; 31: 742–7
- Cronk C. E., Crocker A. C., Pueschel S. M., Slier A. M., Zockai E., Pickens G., Reed R. B. Growth charts for children with Down's syndrome: 1 month to 18 years of age. Pediatrics 1988; 81: 102–10
- Bates G. W., Whitworth N. S. Effect of body weight reduction on plasma androgens in obese infertile women. Fertil. Steril. 1982; 38: 406–9
- Homburg R., West C., Torresani T., Jacobs H. S. Cotreatment with human growth hormone and gonadotropins for induction of ovulation: a controlled clinical trial. Fertil. Steril. 1990; 53: 254–60
- Ibrahim Z. H. Z., Matson P. L., Buck P., Lieberman B. A. The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response. Fertil. Steril. 1991; 55: 202–4
- Barreca A., Minuti F., Volpe A., Cecchelli E., Cella F., Monte P. D., Barreca A., Minuti F., Volpe A., Cecchelli Cella E. F., Del Monte P., Artini P., Giorolano G. Insulin-like growth factor-1 (IGF-1) and IGF-1 binding protein in the follicular fluids of growth hormone treated patients. Clin. Endocrinol. (Oxf.) 1990; 32: 497–505
- Lanzone A., Di Simone N., Castellani R., Fulghesu A. M., Caruso A., Mancuso S. Human growth hormone enhances progesterone production by human luteal cells in vitro: evidence of a. synergistic effect with human chorionic gonadotropin. Fertil. Steril. 1992; 57: 92–6
- Tanner J. M., Whitehouse R. H. A note an the bone age at which patients with true isolated growth hormone deficiency enter puberty. J. Clin. Endocrinol. Metab. 1975; 36: 56–60
- Kulin H. E., Samojlik E., Santen R., Santer S. The effect of gonadotropin in boys with hypopituitarism. Clin. Endocrinol. (Oxf.) 1981; 15: 463–8
- Adashi E. Y., Resnick C. E., Hurwitz A., Ricciarellie E., Hernandez E. R., Roberts C. T., Leroith D., Rosenfeld R. The intra-ovarian IGF system. Growth Regul. 1992; 2: 10–15
- Lanzone A., Fulghesu A. M., Pappalardo S., Proto A., Le Donne M., Andreani C. L., Muscatello R., Caruso A., Mancuso S. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Gynecol. Obstet. Inv. 1990; 29: 149–54